The total investment is 28.6 billion yuan! 30 biomedical industry projects signed successfully

[pharmaceutical network industry trends] on February 22, the network signing ceremony for the series of projects of Xi'an biomedical industry cluster was held in Xi'an high tech Zone There were 30 biomedical industry projects signed, with a total investment of 28.6 billion yuan, involving many fields such as proprietary Chinese medicine, chemical medicine, biological medicine, medical equipment, health tourism, finance, etc Among them, there are 2 projects signed on site, and the other 28 projects are all in the form of "online signing" Specifically, among the contracted projects, 7 are Chinese patent medicine, chemical medicine and biological medicine, and 5 are medical devices It can be seen that the promising prospect of medical and pharmaceutical industry is very considerable Xi'an Xintong Pharmaceutical Research Co., Ltd It is reported that Xi'an Xintong Pharmaceutical Research Co., Ltd plans to invest 300 million yuan to build a research and development and industrialization base for liver targeted innovative drugs At present, there are five innovative drugs in different research and development stages, three of which are expected to be approved for listing in 2021-2024, and the annual sales of the project is expected to reach 6 billion yuan after delivery According to the data, Xi'an Xintong Pharmaceutical Research Co., Ltd is a national high-tech enterprise Mainly engaged in the research and development of chemicals, new Chinese medicine, product registration, I-IV clinical trials The biomedical technology service platform jointly built by the company and Xi'an high tech Industrial Development Zone is a relatively large and innovative new drug R & D institution in Shaanxi Province Yufan Biotechnology Co., Ltd Yufan Biotechnology Co., Ltd plans to invest 100 million yuan to build a preparation center to produce and prepare cart cells for the treatment of refractory recurrent leukemia and lymphoma According to the data, Yufan Biotechnology Co., Ltd focuses on the application of chimeric antigen receptor T-cell immunotherapy (car-t) in tumor treatment Shaanxi Juzi Biotechnology Co., Ltd Shaanxi Juzi Biotechnology Co., Ltd will invest 1.36 billion yuan to build three major projects: Medical repair dressing and high-end medical equipment industrialization project, rare secondary metabolites and probiotics production base project, and e-commerce business incubation base The annual output value of the project is expected to reach 1.8 billion yuan According to the data, Shaanxi Juzi Biotechnology Co., Ltd is a high-tech enterprise dominated by gene engineering and biomaterial engineering, focusing on the three health industry directions of Dermatology, preventive medicine and nutrition medicine Human like collagen has been successfully developed and industrialized in the world by tycoon biology, realizing the transformation from "made in China" to "created in China", and is a model of independent innovation in science and technology in China Shanhaidan Pharmaceutical Co., Ltd R & D and production base of shanhaidan Pharmaceutical Co., Ltd., research and production center project of Xi'an traditional Chinese medicine molecular analysis ancient processing and display, research and development and production base project of Tianyu pharmaceutical minimally invasive sclerotherapy products, a number of independent innovative pharmaceutical and equipment projects settled in Xi'an High Tech zone According to the data, shanhaidan Pharmaceutical Co., Ltd was reorganized and established in 2009 by Xi'an Hongqing pharmaceutical factory and Xi'an Huanghe Pharmaceutical Co., Ltd with a registered capital of 60 million yuan It is a modern state-owned pharmaceutical enterprise integrating research and development, production and sales of Western pharmaceutical preparations Shanhaidan Pharmaceutical Co., Ltd of Shaanxi pharmaceutical holding group is a wholly-owned holding enterprise of Shaanxi pharmaceutical Holding Group Co., Ltd The industry believes that with the implementation of these projects, it will greatly enhance the competitiveness of the local industry, cultivate a number of benchmark enterprises, promote a number of heavy-duty products, and vigorously promote the construction of Xi'an as a biomedical industry highland.